KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Other Non Operating Income (2016 - 2025)

Pacific Biosciences Of California has reported Other Non Operating Income over the past 16 years, most recently at $2.8 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at $2.8 million for Q4 2025, up 114.04% from a year ago — trailing twelve months through Dec 2025 was $14.8 million (changed N/A YoY), and the annual figure for FY2025 was $14.8 million, changed.
  • Other Non Operating Income for Q4 2025 was $2.8 million at Pacific Biosciences Of California, down from $3.0 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for PACB hit a ceiling of $7.6 million in Q4 2022 and a floor of -$19.7 million in Q4 2024.
  • Median Other Non Operating Income over the past 5 years was $2.8 million (2025), compared with a mean of $1.7 million.
  • Biggest five-year swings in Other Non Operating Income: soared 8402.17% in 2022 and later crashed 1069.9% in 2024.
  • Pacific Biosciences Of California's Other Non Operating Income stood at -$92000.0 in 2021, then soared by 8402.17% to $7.6 million in 2022, then plummeted by 73.38% to $2.0 million in 2023, then crashed by 1069.9% to -$19.7 million in 2024, then soared by 114.04% to $2.8 million in 2025.
  • The last three reported values for Other Non Operating Income were $2.8 million (Q4 2025), $3.0 million (Q3 2025), and $4.7 million (Q2 2025) per Business Quant data.